Results 121 to 130 of about 1,738 (165)

Hypokalemic Periodic Paralysis with Arrhythmia

New England Journal of Medicine, 1972
IN 1963, Klein and his co-workers1 described a variant of periodic paralysis in which intermittent attacks of muscular paralysis occurred in patients who also had cardiac arrhythmia.
L P, Levitt, L I, Rose, D M, Dawson
openaire   +2 more sources

Hypokalemic Periodic Paralysis or Hypokalemic Muscle Weakness?

Archives of Neurology, 1981
To the Editor— Bennet and Forman, in their recent report of a case of chronic toluene exposure that had caused tubular dysfunction, loss of potassium, and muscle weakness (Archives1980;37:673), used the term "hypokalemic periodic paralysis" to describe the disease.
O J, Buruma, J J, Schipperheyn
openaire   +2 more sources

Hypokalemic Periodic Paralysis

Archives of Neurology, 1979
To the Editor.— Hypokalemic periodic paralysis has been treated in many ways, such as by the use of potassium supplements and spironolactone to increase the patient's level of potassium 1 and most recently by the use of acetazolamide. 2 This last method is thought not to alter potassium metabolism 3 but rather to work through the creation of metabolic
openaire   +1 more source

Acetazolamide Prophylaxis in Hypokalemic Periodic Paralysis

New England Journal of Medicine, 1968
Abstract When acetazolamide, an agent used to treat hyperkalemic periodic paralysis, was inadvertently found to relieve a patient with the hypokalemic variety, he and another patient were observed to compare this agent with conventional therapy. Well tolerated doses of acetazolamide, 375 to 500 mg daily, eliminated severe attacks and were much more ...
W KING Engel, Robert C Griggs, Griggs Robert C   +2 more
exaly   +3 more sources

Hypokalemic periodic paralysis exacerbated by acetazolamide

Neurology, 1981
Although acetazolamide usually prevents paralytic attacks in hypokalemic periodic paralysis, not all patients benefit from this treatment. We studied a father and two sons in whom attack frequency and severity increased on acetazolamide. Administration of triamterene virtually abolished attacks in three separate single-blind trials totaling more than ...
C F, Torres, R C, Griggs, R T, Moxley, A N, Bender   +3 more
openaire   +2 more sources

Recognizing thyrotoxic hypokalemic periodic paralysis

JAAPA, 2018
ABSTRACT Thyrotoxic hypokalemic periodic paralysis (THPP) is a rare but potentially serious complication of thyrotoxicosis. The resulting muscle weakness is profound, associated with more severe hypokalemia, yet reversible. However, clinicians must be cautious because patients can develop life-threatening hyperkalemia during treatment ...
Kamini, Patel, Jonathan V, McCoy, Patrick M, Davis   +2 more
openaire   +2 more sources

Multiple Sclerosis and Hypokalemic Periodic Paralysis

Archives of Neurology, 1984
To the Editor. —In a recent issue of theArchives, Toglia et al 1 referred to an instance of the association of multiple sclerosis (MS) and hypokalemic paralysis in the same person, which they believed to be the first reported. A similar case history has, in fact, already been recorded from this department.
J, Braham, M, Sadeh
openaire   +2 more sources

The Effect of Acidosis in Hypokalemic Periodic Paralysis

Archives of Neurology, 1976
Metabolic acidosis was produced in two patients with hypokalemic periodic paralysis by the administration of ammonium chloride over a period of three days. The challenging test of glucose and insulin produced a substantially smaller reduction of both serum potassium concentration and muscle strength than when the patients were tested in normal acid ...
M A, Jarrell, M, Greer, T H, Maren
openaire   +2 more sources

HYPOKALEMIC PERIODIC PARALYSIS OF THYROTOXIC ORIGIN

Australian and New Zealand Journal of Medicine, 1987
Abstract A 50‐year‐old Vietnamese man suffered recurrent episodes of hypokalemic periodic paralysis during treatment for thyrotoxicosis. Suspected precipitants of the paralysis were oral prednisolone, strenuous exertion and poor compliance with medications. Propranolol prevented the periodic paralysis. Control of the thyrotoxicosis was complicated by a
J G, McHutchison, R A, Melick, J D, Wark
openaire   +2 more sources

Intravenous Treatment of Hypokalemic Periodic Paralysis

Archives of Neurology, 1983
Acute attacks of weakness in patients with hypokalemic periodic paralysis can usually be treated with oral potassium preparations. Occasional patients, however, require intravenous (IV) potassium administration. We studied a patient with hypokalemic periodic paralysis to determine the effect of using 5% glucose as a diluent for potassium administration
R C, Griggs, J, Resnick, W K, Engel
openaire   +2 more sources